1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | 2022 | |
|---|---|---|
| Revenue | 0.00 | - |
| Gross profit | −34.75k | 73,64% |
| Net profit | −1.84m | 76,48% |
| EBITDA | −2.51m | 8,96% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 929.38€ |
Number of shares | 10.83m |
52-week high/low | 0,00944€ - 0,0000858€ |
| Dividends | No |
Beta | 1,59 |
P/E ratio | 0,00 |
PEG ratio | 0,00 |
P/B ratio | 0,00 |
P/S ratio | 0,00 |
Company profile
Imagin Medical Inc. ist ein Unternehmen für chirurgische Bildgebung mit Schwerpunkt auf Blasenkrebs. Das Unternehmen entwickelt das i/Blue Imaging System, um den Bedarf von Urologen an BLC zu decken. Imagin Medical Inc. wurde 1986 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.
| Name | Imagin Medical |
| CEO | E. James Hutchens |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| IPO | 01/23/2013 |
| Employees | 10 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | IMEXF |
Frankfurt | DPD3.F |
München | DPD3.MU |
Discover assets
Shareholders of Imagin Medical also invest in the following assets





